503 related articles for article (PubMed ID: 11304496)
1. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
2. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
4. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
6. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
7. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
8. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.
Suzuki A; Hanada T; Mitsuyama K; Yoshida T; Kamizono S; Hoshino T; Kubo M; Yamashita A; Okabe M; Takeda K; Akira S; Matsumoto S; Toyonaga A; Sata M; Yoshimura A
J Exp Med; 2001 Feb; 193(4):471-81. PubMed ID: 11181699
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
12. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
13. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Delgado M; Ganea D
J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
[TBL] [Abstract][Full Text] [Related]
16. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of novel CIS family genes.
Masuhara M; Sakamoto H; Matsumoto A; Suzuki R; Yasukawa H; Mitsui K; Wakioka T; Tanimura S; Sasaki A; Misawa H; Yokouchi M; Ohtsubo M; Yoshimura A
Biochem Biophys Res Commun; 1997 Oct; 239(2):439-46. PubMed ID: 9344848
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
[TBL] [Abstract][Full Text] [Related]
19. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
20. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
